[Differentiation and evaluation of calcium antagonists in therapy of arterial hypertension].
Holzgreve
H
H
h.holzgreve@t-online.de
D002121:Calcium Channel Blockers / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D009203:Myocardial Infarction / Q000517:prevention & control; D020521:Stroke / Q000517:prevention & control; D016896:Treatment Outcome
D002121:Calcium Channel Blockers; D003692:Delayed-Action Preparations